HK1098192A1 - Analysis of saccharide vaccines without interference - Google Patents

Analysis of saccharide vaccines without interference

Info

Publication number
HK1098192A1
HK1098192A1 HK07105566.6A HK07105566A HK1098192A1 HK 1098192 A1 HK1098192 A1 HK 1098192A1 HK 07105566 A HK07105566 A HK 07105566A HK 1098192 A1 HK1098192 A1 HK 1098192A1
Authority
HK
Hong Kong
Prior art keywords
saccharide
serogroup
batch
concentration
interference
Prior art date
Application number
HK07105566.6A
Other languages
English (en)
Inventor
Angela Bardotti
Daniela Proietti
Stefano Ricci
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32117883&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1098192(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of HK1098192A1 publication Critical patent/HK1098192A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/22—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
HK07105566.6A 2004-03-17 2007-05-28 Analysis of saccharide vaccines without interference HK1098192A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0406013.3A GB0406013D0 (en) 2004-03-17 2004-03-17 Analysis of saccharide vaccines without interference
PCT/IB2005/000987 WO2005090986A2 (fr) 2004-03-17 2005-03-17 Analyse de vaccins saccharidiques sans interference

Publications (1)

Publication Number Publication Date
HK1098192A1 true HK1098192A1 (en) 2007-07-13

Family

ID=32117883

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07105566.6A HK1098192A1 (en) 2004-03-17 2007-05-28 Analysis of saccharide vaccines without interference

Country Status (19)

Country Link
US (3) US20080305126A1 (fr)
EP (4) EP3035056A1 (fr)
JP (2) JP4692852B2 (fr)
CN (1) CN1981195B (fr)
AT (2) ATE500510T1 (fr)
AU (2) AU2005224459B2 (fr)
BR (1) BRPI0508890A (fr)
CA (1) CA2560224C (fr)
CY (1) CY1111272T1 (fr)
DE (2) DE602005026635D1 (fr)
ES (1) ES2353701T3 (fr)
GB (1) GB0406013D0 (fr)
HK (1) HK1098192A1 (fr)
NZ (2) NZ570193A (fr)
PL (1) PL1725872T3 (fr)
PT (1) PT1725872E (fr)
RU (1) RU2371725C2 (fr)
SI (1) SI1725872T1 (fr)
WO (2) WO2005090985A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0411387D0 (en) * 2004-05-21 2004-06-23 Chiron Srl Analysis of saccharide length
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
GB0605757D0 (en) * 2006-03-22 2006-05-03 Chiron Srl Separation of conjugated and unconjugated components
GB0612854D0 (en) 2006-06-28 2006-08-09 Novartis Ag Saccharide analysis
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
US8797995B2 (en) * 2007-01-18 2014-08-05 Cisco Technology, Inc. Device-assisted layer 3 handoff for mobile services
GB0713880D0 (en) * 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
US8207298B2 (en) * 2008-05-01 2012-06-26 Archemix Corp. Methods of separating biopolymer conjugated molecules from unconjugated molecules
TW201009337A (en) * 2008-05-30 2010-03-01 Intervet Int Bv Analytical method to monitor vaccine potency and stability
US20100098021A1 (en) * 2008-10-16 2010-04-22 Cisco Technology, Inc. Policy-driven layer 3 handoff for mobile services
WO2011109900A1 (fr) * 2010-03-10 2011-09-15 Inovobiologic, Inc. Aliment comprenant du glucomannane, de la gomme de xanthane et un alginate pour le traitement de troubles métaboliques
MX350142B (es) 2010-08-23 2017-08-28 Wyeth Llc * Formulaciones estables de antigenos rlp2086 de neisseria meningitidis.
EP3549601B1 (fr) 2010-09-10 2021-02-24 Wyeth LLC Dérivés non-lipidés des antigènes orf2086 de neisseria meningitidis
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
MX359256B (es) 2012-03-09 2018-09-19 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.
WO2013174832A1 (fr) 2012-05-22 2013-11-28 Novartis Ag Conjugué de sérogroupe x de méningocoque
CN102735809B (zh) * 2012-06-29 2015-04-29 成都欧林生物科技股份有限公司 测定Hib结合疫苗中高分子结合物含量的方法
EP2964665B1 (fr) 2013-03-08 2018-08-01 Pfizer Inc Polypeptides immunogènes de fusion
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CN107249626A (zh) 2015-02-19 2017-10-13 辉瑞大药厂 脑膜炎奈瑟球菌组合物及其方法
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
SG11201906519RA (en) 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof
BR112021002156A2 (pt) 2018-08-06 2021-05-11 Nielsen Biosciences, Inc. tratamento de verrugas
CA3152573A1 (fr) 2019-10-01 2021-04-08 Biological E Limited Procedes de quantification de glucides

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB323103A (en) 1928-12-07 1929-12-24 Fred Cunningham Firth Improvements relating to shaper mechanism for winding yarn on weft bobbins in spinning mules
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
NL8802046A (nl) 1988-08-18 1990-03-16 Gen Electric Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
DE3841091A1 (de) 1988-12-07 1990-06-13 Behringwerke Ag Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
ES2055785T3 (es) 1989-01-17 1994-09-01 Eniricerche Spa Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
WO1991001146A1 (fr) 1989-07-14 1991-02-07 Praxis Biologics, Inc. Cytokine et supports d'hormone pour vaccins conjugues
IT1237764B (it) 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
EP0462794B1 (fr) * 1990-06-21 1998-09-09 Oxford GlycoSciences (UK) Limited Procédé automatisé pour le clivage de biomolécules
EP0471177B1 (fr) 1990-08-13 1995-10-04 American Cyanamid Company Hemagglutinine filamenteuse de Bordetella pertussis à titre de molécules porteuses pour vaccins conjugués
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
IT1262896B (it) 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
IL102687A (en) 1992-07-30 1997-06-10 Yeda Res & Dev Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
ES2171418T3 (es) 1992-08-31 2002-09-16 Baxter Healthcare Sa Vacunas contra neisseria meningitidis del grupo c.
US5425946A (en) 1992-08-31 1995-06-20 North American Vaccine, Inc. Vaccines against group C Neisseria meningitidis
ATE400295T1 (de) 1995-06-07 2008-07-15 Glaxosmithkline Biolog Sa Vakzine mit einem polysaccharide antigen- trägerprotein konjugat und freiem trägerprotein
US6299881B1 (en) 1997-03-24 2001-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
CZ302615B6 (cs) * 1997-12-23 2011-08-03 Baxter Healthcare S.A. Zpusob cištení kapsulárních polysacharidu od bunecných komponent gramnegativních a grampozitivních bakterií a modifikovaný kapsulární polysacharid
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
EP1071465A1 (fr) 1998-03-18 2001-01-31 Ronai, Peter Verres amorphes pour stabiliser des produits sensibles
HUP0103100A3 (en) 1998-08-19 2005-11-28 Baxter Healthcare Sa Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
DE60038166T2 (de) 1999-03-19 2009-03-12 Glaxosmithkline Biologicals S.A., Rixensart Impfstoff gegen bakterielle antigene
FR2791895B1 (fr) 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
EP1165796A2 (fr) 1999-04-09 2002-01-02 Techlab, Inc. Support proteique recombinant de la toxine a pour vaccins conjugues polysaccharides
EP2275129A3 (fr) 2000-01-17 2013-11-06 Novartis Vaccines and Diagnostics S.r.l. Vaccin omv complèté contre la méningocoque
GB0007432D0 (en) 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
EP1322328B1 (fr) 2000-07-27 2014-08-20 Children's Hospital & Research Center at Oakland Vaccins pour protection a large spectre contre les maladies causees par neisseria meningitidis
GB0103170D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
ES2388848T3 (es) * 2001-01-23 2012-10-19 Sanofi Pasteur Inc. Vacuna meningocócica polivalente preparada con un conjugado de polisacárido y proteína
WO2002091998A2 (fr) 2001-05-11 2002-11-21 Aventis Pasteur, Inc. Nouveau vaccin conjugue contre la meningite
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1410532A (zh) * 2002-03-21 2003-04-16 上海凡华生物技术有限公司 一种人/山羊肝嵌合模型的建立及其鉴定方法
PT1490409E (pt) 2002-03-26 2009-04-03 Novartis Vaccines & Diagnostic Sacáridos modificados possuindo uma estabilidade melhorada em água
JP4061960B2 (ja) * 2002-04-26 2008-03-19 株式会社日立製作所 コンピュータシステム
CN1428434A (zh) * 2002-11-14 2003-07-09 中国科学院水生生物研究所 一种检测微囊藻产毒的方法
EP1624888B1 (fr) * 2003-05-07 2016-10-12 Sanofi Pasteur, Inc. Conjugues de polysaccharides-proteines derivatises meningococciques multivalents et vaccin correspondant
JP2007516219A (ja) * 2003-05-07 2007-06-21 アヴェンティス パストゥール インコーポレイテッド 髄膜炎菌ワクチン接種に対する免疫原性の増強の方法
CN102023212B (zh) * 2010-09-28 2014-04-02 汕头大学医学院 一种流感病毒神经氨酸酶抗体的快速检测方法

Also Published As

Publication number Publication date
WO2005090986A2 (fr) 2005-09-29
AU2005224459A1 (en) 2005-09-29
RU2371725C2 (ru) 2009-10-27
BRPI0508890A (pt) 2007-09-11
EP3035056A1 (fr) 2016-06-22
US20080305126A1 (en) 2008-12-11
DE602005026635D1 (de) 2011-04-14
JP2007529736A (ja) 2007-10-25
EP1725871A1 (fr) 2006-11-29
CA2560224A1 (fr) 2005-09-29
JP2011013226A (ja) 2011-01-20
US20080286300A1 (en) 2008-11-20
RU2006136270A (ru) 2008-04-27
EP2290366A1 (fr) 2011-03-02
NZ570193A (en) 2010-02-26
SI1725872T1 (sl) 2011-03-31
EP1725872A2 (fr) 2006-11-29
ATE500510T1 (de) 2011-03-15
AU2005224459B2 (en) 2011-02-03
EP1725872B8 (fr) 2011-04-20
CY1111272T1 (el) 2015-08-05
EP1725871B8 (fr) 2011-06-15
US20120171241A1 (en) 2012-07-05
US8137680B2 (en) 2012-03-20
NZ549907A (en) 2008-10-31
ES2353701T3 (es) 2011-03-04
PT1725872E (pt) 2011-02-08
JP4692852B2 (ja) 2011-06-01
CN1981195A (zh) 2007-06-13
EP1725871B1 (fr) 2011-03-02
CN1981195B (zh) 2012-07-04
ATE487137T1 (de) 2010-11-15
PL1725872T3 (pl) 2011-06-30
GB0406013D0 (en) 2004-04-21
DE602005024523D1 (de) 2010-12-16
AU2011200950A1 (en) 2011-03-24
WO2005090986A3 (fr) 2006-04-13
CA2560224C (fr) 2014-10-21
WO2005090985A1 (fr) 2005-09-29
EP1725872B1 (fr) 2010-11-03

Similar Documents

Publication Publication Date Title
HK1098192A1 (en) Analysis of saccharide vaccines without interference
EP2277537A3 (fr) Vaccin conjugué combiné contre Neisseria meningitidis
MXPA05007886A (es) Vacunas para la mucosa con adyuvante de quitosan y antigenos para meningococo.
ATE552844T1 (de) Injizierbarer impfstoff gegen multiple meningokokken-serogruppen
RU2007102016A (ru) Пространственный анализ конъюгатов сахаридов с помощью gpc и sec-mals
MA30065B1 (fr) Vaccin
GEP20053691B (en) Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
EP2308505A3 (fr) Vaccins multiples comprenant le sérogroupe C de Neisseria meningitidis
WO2005105140A3 (fr) Integration d'une vaccination conjuguee antimeningococcique
MA30071B1 (fr) Vaccin
BR9813930A (pt) antìgeno neisserial
RU2006140958A (ru) Иммунизация против менингококков серогруппы y с помощью белков
WO2001037863A3 (fr) Compositions comprenant des antigenes contre les serogroupes b et c de neisseria meningitidis
WO2006067632A3 (fr) Vaccins à base de conjugués de saccharide
GB0323103D0 (en) De-acetylated saccharides
EP1379272A4 (fr) Mimetiques moleculaires d'epitopes b meningococciques qui elicitent des anticorps fonctionnellement actifs
PT1154790E (pt) Reforco da actividade bactericida de antigenios contra a neisseria com oligonucleotidos contendo motivos cg
Centers for Disease Control and Prevention (CDC Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005
WO2004103400A3 (fr) Conjugues de polysaccharides-proteines derivatises meningococciques multivalents et vaccin correspondant
WO2005000345A3 (fr) Procede d'immunisation contre la bacterie neisseria meningitidis serogroupes a et c

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150317